Preventing the antimicrobial resistance health crisis

Preventing the antimicrobial resistance health crisis

In this Sustainability Leaders podcast episode, we discuss the history of antibiotic use that brought us to our current crisis today.

November 18 marked the start of World Antimicrobial Awareness Week, which aims to bring attention to the ever-evolving public health crisis of antimicrobial resistance (AMR) due to the overuse of antibiotics around the world.

Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance, and James Anderson, Head of AMR and Corporate Government Affairs at GlaxoSmithKline, join the podcast to discuss the history of antibiotic use on humans, livestock and plants that brought us to our current crisis today. Plus, they provide an overview of engagement in this space to change behaviors around the use of antibiotics globally.

In this episode:

  • What is antimicrobial resistance and why is it such a pressing issue?
  • How the AMR Industry Alliance is combatting antibiotic overuse
  • Consumers and investors hold power to change antibiotic usage
  • The effects of inaction on antimicrobial resistance, and how we can change the trajectory


Dame Sally Davies: The fast pandemic, I talk about a lobster in boiling water of COVID-19, and it’s making a lot of noise, and it’s waking everyone up to the threat that can come when healthcare goes wrong. Meanwhile, there’s this slow, creeping pandemic of resistance by the bugs and microbes to their treatments, whether it’s TB, malaria, HIV, fungi or indeed bacteria when it’s antibiotics that the resistance has developed to.

Michael Torrance: Welcome to “Sustainability Leaders.” I’m Michael Torrance, Chief Sustainability Officer with BMO Financial Group. On this show, we will talk with leading sustainability practitioners from the corporate, investor, academic and NGO communities to explore how this rapidly evolving field of sustainability is impacting global investment, business practices and our world.
Disclaimer: The views expressed here are those of the participants and not those of Bank of Montreal, its affiliates or subsidiaries.
Alice Evans: Welcome to the “BMO Sustainability Leaders Podcast.” My name is Alice Evans, and I’m one of the two co-heads of our Responsible Investment Team at BMO GAM. At BMO GAM, we have a team of analysts with expertise on different social, environmental and governance issues, and we research those issues that have most relevance to the companies that our clients invest in, and our team leads BMO GAM’s Engagement Program, entering into dialog with those companies on those key issues to request and encourage improved management of those issues.
Catherine McCabe
Catherine McCabe
Senior Associate, Analyst

Catherine McCabe joined BMO Global Asset Management in 2015 and has been an Analyst in the Responsible Investment team since 2018. She was previously the Product Specialist for the Emerging Market Debt team in London. She covers healthcare companies and public health issues, and co-ordinates and conducts research for the Responsible Fund range. Catherine has passed Level I of the CFA program and graduated from the University of Oxford with a degree in Modern Languages (German and Italian).

Catherine McCabe
Alice Evans
Alice Evans
Responsible Investment Strategist

Alice is Managing Director and Co-Head of the Responsible Investment Team. She returned to BMO Global Asset Management in 2018 having previously worked here as a fund manager from 2010 to 2016, most recently as Co-Lead Manager of the Responsible Global Equity Fund. Prior to BMO, Alice gained ten years of investment experience initially at JP Morgan Asset Management then at Henderson Global Investors, as a fund manager on the Sustainable & Responsible Investment funds, and as a healthcare sector specialist. Alice has a successful track record as a portfolio manager in responsible investment and brings the Responsible Investment team first-hand experience of integrating ESG issues into investment research and decision making. Outside BMO, Alice holds a pro bono role as a panel member for the funding programme of the National Institute of Health Research. Alice holds an MSci in Physics from the University of Bristol and is a CFA Charterholder.

Alice Evans
Share on twitter
Share on linkedin
Share on email

Key topics

Team member placeholder


Legal and regulatory disclosures

For professional clients and/or qualified investors only

Nothing on this website is, or is intended to be, an offer, advice, or an invitation to buy or sell any investments, in any jurisdiction where, or to anyone whom it would be unlawful to do so. Please read our full terms and conditions before proceeding further with any investment product referred to on this website. This website may not be suitable for everyone, and if you are at all unsure whether an investment product referenced on this website will meet your individual needs, please seek professional advice before proceeding further with such product. I have read and accept the terms and conditions and cookie policy of this site.